AMA Journal of Ethics

Heightened caution, improved physician and patient communication, and equitable access are key priorities.

Beatrice L. Brown joins Ethics Talk to discuss her article, coauthored with Dr Aaron S Kesselheim: "How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices?"

Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability.

Allocating resources for interventions requires consensus among stakeholders with a plurality of perspectives about how to weigh antimicrobial stewardship interventions’ risks and benefits.

A wire, plaster, and wood sculpture of a DNA double helix with one mismatched base pair considers how we might justly weigh overall health equity against extremely costly interventions for uncommon genetic illnesses.

Drs David D. Kim and Anirban Basu join Ethics Talk to discuss their article: "How Does Cost-Effectiveness Analysis Inform Health Care Decisions?"

Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied.

CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide.

Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm.

Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity.